589 related articles for article (PubMed ID: 27749550)
1. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
Kong X; Kong Y; Zhang F; Wang T; Yan J
Medicine (Baltimore); 2016 Oct; 95(40):e4949. PubMed ID: 27749550
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis.
Bacq Y; Sentilhes L; Reyes HB; Glantz A; Kondrackiene J; Binder T; Nicastri PL; Locatelli A; Floreani A; Hernandez I; Di Martino V
Gastroenterology; 2012 Dec; 143(6):1492-501. PubMed ID: 22892336
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
Chappell LC; Chambers J; Dixon PH; Dorling J; Hunter R; Bell JL; Bowler U; Hardy P; Juszczak E; Linsell L; Rounding C; Smith A; Williamson C; Thornton JG
Trials; 2018 Nov; 19(1):657. PubMed ID: 30482254
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
Grymowicz M; Czajkowski K; Smolarczyk R
Scand J Gastroenterol; 2016 Jan; 51(1):78-85. PubMed ID: 26152830
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid.
Joutsiniemi T; Timonen S; Linden M; Suvitie P; Ekblad U
BMC Gastroenterol; 2015 Jul; 15():92. PubMed ID: 26215400
[TBL] [Abstract][Full Text] [Related]
6. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations.
Vasavan T; Deepak S; Jayawardane IA; Lucchini M; Martin C; Geenes V; Yang J; Lövgren-Sandblom A; Seed PT; Chambers J; Stone S; Kurlak L; Dixon PH; Marschall HU; Gorelik J; Chappell L; Loughna P; Thornton J; Pipkin FB; Hayes-Gill B; Fifer WP; Williamson C
J Hepatol; 2021 May; 74(5):1087-1096. PubMed ID: 33276032
[TBL] [Abstract][Full Text] [Related]
7. Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis.
Gümüş Güler B; Özler S
Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):271-276. PubMed ID: 31919038
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.
Glantz A; Marschall HU; Lammert F; Mattsson LA
Hepatology; 2005 Dec; 42(6):1399-405. PubMed ID: 16317669
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin-releasing hormone expression in patients with intrahepatic cholestasis of pregnancy after ursodeoxycholic acid treatment: an initial experience.
Zhou F; Zhang L; He MM; Liu ZF; Gao BX; Wang XD
Curr Med Res Opin; 2014 Aug; 30(8):1529-35. PubMed ID: 24665980
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid therapy in intrahepatic cholestasis of pregnancy: Results in real-world conditions and factors predictive of response to treatment.
Bacq Y; le Besco M; Lecuyer AI; Gendrot C; Potin J; Andres CR; Aubourg A
Dig Liver Dis; 2017 Jan; 49(1):63-69. PubMed ID: 27825922
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological interventions for treating intrahepatic cholestasis of pregnancy.
Walker KF; Chappell LC; Hague WM; Middleton P; Thornton JG
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD000493. PubMed ID: 32716060
[TBL] [Abstract][Full Text] [Related]
12. The effects of ursodeoxycholic acid treatment for intrahepatic cholestasis of pregnancy on maternal and fetal outcomes: a meta-analysis including non-randomized studies.
Grand'Maison S; Durand M; Mahone M
J Obstet Gynaecol Can; 2014 Jul; 36(7):632-641. PubMed ID: 25184983
[TBL] [Abstract][Full Text] [Related]
13. Interventions for treating cholestasis in pregnancy.
Gurung V; Middleton P; Milan SJ; Hague W; Thornton JG
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD000493. PubMed ID: 23794285
[TBL] [Abstract][Full Text] [Related]
14. [Meta-analysis of ursodeoxycholic acid and S-adenosylmethionine for improving the outcomes of intrahepatic cholestasis of pregnancy].
Zhou F; Gao B; Wang X; Li J
Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):299-304. PubMed ID: 25173231
[TBL] [Abstract][Full Text] [Related]
15. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid.
Brites D
Ann Hepatol; 2002; 1(1):20-8. PubMed ID: 15114292
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience.
Zapata R; Sandoval L; Palma J; Hernández I; Ribalta J; Reyes H; Sedano M; Tohá D; Silva JJ
Liver Int; 2005 Jun; 25(3):548-54. PubMed ID: 15910492
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy.
Parízek A; Simják P; Cerný A; Sestinová A; Zdenková A; Hill M; Dusková M; Vlk R; Kokrdová Z; Koucký M; Vítek L
Ann Hepatol; 2016; 15(5):757-61. PubMed ID: 27493115
[TBL] [Abstract][Full Text] [Related]
18. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment.
Rodrigues CM; Marín JJ; Brites D
Gut; 1999 Sep; 45(3):446-52. PubMed ID: 10446117
[TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholic acid improves pregnancy outcome in patients with intrahepatic cholestasis during pregnancy: A protocol for systematic review and meta-analysis.
Wang Y; Peng X; Zhang Y; Yang Q; Xiao Y; Chen Y
Medicine (Baltimore); 2021 Jan; 100(4):e23627. PubMed ID: 33530164
[TBL] [Abstract][Full Text] [Related]
20. S-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial.
Floreani A; Paternoster D; Melis A; Grella PV
Eur J Obstet Gynecol Reprod Biol; 1996 Aug; 67(2):109-13. PubMed ID: 8841797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
